期刊文献+

短期胰岛素泵强化治疗对初诊2型糖尿病患者胰岛功能的影响 被引量:5

Influence of short-term insulin intensive therapy on pancreatic islets function of newly-diagnosed type 2 diabetes mellitus patients
在线阅读 下载PDF
导出
摘要 目的探讨短期胰岛素泵(CSII)强化治疗对初诊2型糖尿病患者胰岛功能的影响。方法选择2009年1月~2011年6月我院收治的86例初诊2型糖尿病患者进行CSII强化治疗2周,观察比较治疗前后空腹血糖(FPG)、餐后2 h血糖(2 h PG)、空腹胰岛素(FINS)、餐后2 h胰岛素(2 h INS)、糖化血红蛋白A1c(HbA1c)、胰岛素分泌指数(HOMA-β)和胰岛素抵抗指数(HOMA-IR)的变化情况。结果 FINS、2 h INS、HOMA-β水平较治疗前均明显上升(均P〈0.05);FPG、2 h PG、HbA1c、HOMA-IR水平较治疗前均明显下降(均P〈0.05)。 Objective To investigate the impact of short-term continuous subcutaneous insulin infusion(CSII) intensive therapy on pancreatic islets function of the newly-diagnosed type 2 diabetes mellitus(T2DM) patients.Methods 86 cases of newly-diagnosed T2DM patients were selected in our hospital from January 2009 to June 2011 and two weeks of CSII therapy were given.The change of the levels of the fasting plasma glucose(FPG),2 hours postpradial glucose(2 h PG),fasting insulin(FINS),2 hours postpradial insulin(2 h INS),glycosylated hemoglobin A1c(HbA1c),insulin secretion indexes(HOMA-β) and insulin resistance index(HOMA-IR) were observed and compared before and after CSII therapy.Results After two weeks intensive treatment of CSII,the levels of FINS,2 h INS,HOMA-β increased significantly than before treatment(P 〈 0.05).After treatment the levels of FPG,2 h PG,HbA1c,HOMA-IR decreased significantly than before treatment(P 〈 0.05).Conclusion There is a significant effect of the short-term CSII intensive therapy on pancreatic islets function of the newly-diagnosed T2DM patients
作者 罗锐
出处 《中国医药导报》 CAS 2012年第7期155-156,共2页 China Medical Herald
关键词 胰岛素泵 2型糖尿病 胰岛Β细胞功能 胰岛素抵抗 Continuous subcutaneous insulin infusion Type 2 diabetes mellitus Islet βcell function Insulin resistance
  • 相关文献

参考文献13

二级参考文献111

共引文献68

同被引文献54

  • 1Kirstine Brown Frandsen.胰岛素类似物Detemir与体重变化[J].国际内分泌代谢杂志,2006,26(3):198-199. 被引量:2
  • 2刘秀玲,王树华,刘阁玲,项岫秀,李伟娟.胰岛素泵强化治疗糖尿病225例临床疗效观察[J].中国综合临床,2006,22(12):1146-1146. 被引量:2
  • 3Feichtner F, Mader JK,Schaller R, et al. A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algorithm[J]. J Diabetes Sci Technol, 2011,5 (4) :901-905.
  • 4赵庆斌,王惠芳,孙超峰,马爱群,崔长琮.短期胰岛素泵强化治疗对初诊2型糖尿病患者胰岛功能的影响及其氧化应激机制[J].南方医科大学学报,2007,27(12):1878-1879. 被引量:25
  • 5Satoh K, ODell M R, Soe N N, et al. Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice [ J ]. J Exp Med, 2011, 208( 1 ) :53-66.
  • 6Ramachandran S, Venugopal A, Sathisha K, et al. Pro- teomic profiling of high glucose primed monocytes identi- fies cyclophilin A as a potential secretory marker of in- flammation in type 2 diabetes [ J ]. Proteomics, 2012,12 (18) :2808-2821.
  • 7World Health Organization. Definition, diagnosis and clas- sification of diabetes me|litus and its complication: report of a WHO consultation[ R]. Geneva: WHO ,1999:1-44.
  • 8Satoh K, Matoba T, Suzuki J, et al. Cyclophilin A medi- ates vascular remode|ing by promoting inflammation and vascular smooth muscle cell proliferation[ J]. Circulation, 2008,117 ( 24 ) : 3088-3098.
  • 9Seizer P, Geisler T, Bigalke B, et al. EMMPRIN and its ligand Cyclophilin A as novel diagnostic markers in in- flammatory cardiomyopathy[ J] . Int J Cardiol, 2011,163 (3) :299-304.
  • 10Satoh K, Fukumoto Y, Sugimura K, et al. Plasma cyclo- philin A is a novel biomarker for coronary artery disease [J]. Circ J, 2013,77(2) :447-455.

引证文献5

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部